Elevated Soluble Galectin-3 as a Marker of Chemotherapy Efficacy in Breast Cancer Patients: A Prospective Study.

Arooj ShafiqJanuary MooreAliya SulemanSabeen FaizOmar FarooqAdnan ArshadMohammad TehseenAmmarah ZafarSyed Haider AliNasir Ud DinAsif LoyaNeelam SiddiquiFatima K Rehman

Published in: International journal of breast cancer (2020)

The findings support the use of plasma Gal-3 as a marker for chemotherapy efficacy when no residual tumor is visible through imaging. Furthermore, stromal levels in any remaining tumors postchemotherapy can also be used to predict long-term prognosis in patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
locally advanced
peritoneal dialysis
prognostic factors
high resolution
bone marrow
squamous cell carcinoma
patient reported outcomes
patient reported